Literature DB >> 21965657

The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.

Chien-Hung Chen1, Dos D Sarbassov.   

Abstract

In higher eukaryotes, growth factors promote anabolic processes and stimulate cell growth, proliferation, and survival by activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway. Deregulation of PI3K/Akt signaling is linked to human diseases, including cancer and metabolic disorders. The PI3K-dependent signaling kinase complex mTORC2 (mammalian target of rapamycin complex 2) has been defined as the regulatory Ser-473 kinase of Akt. The regulation of mTORC2 remains very poorly characterized. We have reconstituted mTORC2 by its assembly in vitro or by co-expression its four essential components (rictor, SIN1, mTOR, mLST8). We show that the functional mTOR kinase domain is required for the mTORC2 activity as the Ser-473 kinase of Akt. We also found that mTOR by phosphorylation of SIN1 prevents its lysosomal degradation. Thus, the kinase domain of mTOR is required for the functional activity of mTORC2, and it controls integrity of mTORC2 by maintaining the protein stability of SIN1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965657      PMCID: PMC3220582          DOI: 10.1074/jbc.M111.282590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

2.  FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions.

Authors:  R T Peterson; P A Beal; M J Comb; S L Schreiber
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 3.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.

Authors:  Maria A Frias; Carson C Thoreen; Jacob D Jaffe; Wayne Schroder; Tom Sculley; Steven A Carr; David M Sabatini
Journal:  Curr Biol       Date:  2006-08-17       Impact factor: 10.834

5.  Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.

Authors:  Qian Yang; Ken Inoki; Tsuneo Ikenoue; Kun-Liang Guan
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

6.  Endoplasmic reticulum is a main localization site of mTORC2.

Authors:  Delphine R Boulbés; Tattym Shaiken; Dos D Sarbassov
Journal:  Biochem Biophys Res Commun       Date:  2011-08-16       Impact factor: 3.575

7.  Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site.

Authors:  Siraj M Ali; David M Sabatini
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

8.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

9.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.

Authors:  Chiyo Shiota; Jeong-Taek Woo; Jill Lindner; Kathy D Shelton; Mark A Magnuson
Journal:  Dev Cell       Date:  2006-09-07       Impact factor: 12.270

10.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

View more
  22 in total

Review 1.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

2.  c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis.

Authors:  Natalie M Walker; Serina M Mazzoni; Ragini Vittal; Diane C Fingar; Vibha N Lama
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 3.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 4.  mTOR inhibitors in urinary bladder cancer.

Authors:  R Pinto-Leite; R Arantes-Rodrigues; Nuno Sousa; P A Oliveira; L Santos
Journal:  Tumour Biol       Date:  2016-05-27

5.  Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.

Authors:  Graham Dominick; Darlene E Berryman; Edward O List; John J Kopchick; Xinna Li; Richard A Miller; Gonzalo G Garcia
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

Review 6.  Cutting through the complexities of mTOR for the treatment of stroke.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

7.  Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy.

Authors:  Xu Qian; Xinjian Li; Qingsong Cai; Chuanbao Zhang; Qiujing Yu; Yuhui Jiang; Jong-Ho Lee; David Hawke; Yugang Wang; Yan Xia; Yanhua Zheng; Bing-Hua Jiang; David X Liu; Tao Jiang; Zhimin Lu
Journal:  Mol Cell       Date:  2017-02-23       Impact factor: 17.970

Review 8.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

9.  Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.

Authors:  Chien-Hung Chen; Vladimir Kiyan; Assylbek A Zhylkibayev; Dubek Kazyken; Olga Bulgakova; Kent E Page; Rakhmet I Bersimbaev; Eric Spooner; Dos D Sarbassov
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

Review 10.  mTOR: on target for novel therapeutic strategies in the nervous system.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Trends Mol Med       Date:  2012-12-19       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.